RESUMEN
The design of appropriate materials is required for biomedical applications (e.g. drug delivery systems) in improving people's health care processes. This study focused on the incorporation of nanosized hydroxyapatite (n-HA) with different ratios (ranging from 0.1 wt% to 0.5 wt%) into the poly (ε-caprolactone)/ poly (ethylene oxide) (PCL/PEO) blend matrix loaded or unloaded with curcumin. Composite fibrous material systems were successfully fabricated by the electrospinning technique without the occurrence of bead defects. In addition to the morphological and physicochemical properties of the material systems obtained, the in vitro curcumin release performance was investigated. Further, anti-cancer activity against breast cancer cell line (MCF-7) was examined by MTT assay. Fourier transform infrared spectroscopy and X-ray diffraction characterizations of the fabricated fibrous materials exhibited the interaction of PCL/PEO, n-HA, and curcumin. The 0.3 wt% n-HA incorporated fibrous materials showed a much slower curcumin release manner along with the highest cytotoxicity against MCF-7 cells. The findings obtained from this research are expected to contribute to the appropriate design of nanofiber-based composite materials not only for drug delivery systems but also for the fabrication of biomaterials toward different biomedical applications.
Asunto(s)
Curcumina , Nanofibras , Biopolímeros , Liberación de Fármacos , Durapatita , Humanos , Poliésteres , Espectroscopía Infrarroja por Transformada de FourierRESUMEN
The study aimed to investigate the effects of surface treatments, including plasma, on the peel bond strength between two maxillofacial silicones and two resins with and without thermocycling. Forty-eight experimental groups (n=10) were generated incorporating the two different resins (auto-polymerizing acrylic resin and light-curing urethane dimethacrylate resin [AR and LR, respectively]), two different silicones (M511 and Z004), aging (thermocycled/no thermocycling), and six different surface treatments, including polishing, grinding, polishing+argon plasma, polishing+oxygen plasma, grinding+argon plasma, and grinding+oxygen plasma. Surface topography of a specimen from each surface treatment group was examined by atomic force microscopy. After surface treatments, silicones were polymerized. The peel bond strength values of the control and thermocycled groups were determined. Atomic force microscopy showed that surface topographies of the ground specimens were irregular. Polished specimens showed higher peel bond strength than ground specimens. Plasma application appeared to have improved the bond strength between the resins and silicones.
Asunto(s)
Recubrimiento Dental Adhesivo , Siliconas , Resinas Acrílicas , Análisis del Estrés Dental , Ensayo de Materiales , Propiedades de SuperficieRESUMEN
The fabrication of electrospun composite nanofiber mats used as drug delivery systems with controlled release property is of general interest in biomaterial sciences. The aim of this study was to investigate the effect of MWCNTs on the release profile of the hydrophilic drug. For this aim, tetracycline hydrochloride (TCH) loaded poly (lactic acid) (PLA)/polyvinylpyrrolidone (PVP)/TCH-multiwall carbon nanotubes (MWCNTs) composite fibrous mats were fabricated by electrospinning process, and the drug release profile, release kinetics and cytotoxicity were evaluated to determine the potential for utilization as drug delivery systems. Furthermore, the morphological and physicochemical properties of the composite PLA/PVP/TCH-MWCNTs fibrous mats were characterized. The results demonstrated that TCH and MWCNTs were successfully loaded into the PLA/PVP biopolymeric matrix and the addition of TCH or MWCNTs did not alter the uniform and beadless fibrous structure of the PLA/PVP fibers, resulting in increased Young's modulus and maintained the fibrous structure of the composite mats. Moreover, MWCNTs loaded electrospun mats showed much more controlled drug release manner, increased significantly the drug encapsulation efficiency and reduced the burst release of TCH. In vitro cytotoxicity assay showed that the PLA/PVP/TCH-MWCNTs composite mats did not have a toxic effect on the human umbilical vein endothelial cells (HUVECs). With the improved physicochemical and mechanical properties, controlled drug release-profile and cytocompatibility, the fabricated composite nanofiber mats may be used as therapeutic materials for the biomedical applications as drug delivery systems.
Asunto(s)
Antibacterianos/química , Nanotubos de Carbono/química , Tetraciclina/química , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Preparaciones de Acción Retardada/administración & dosificación , Preparaciones de Acción Retardada/química , Liberación de Fármacos , Células Endoteliales de la Vena Umbilical Humana/efectos de los fármacos , Humanos , Microscopía Electrónica de Rastreo , Nanotubos de Carbono/ultraestructura , Poliésteres/química , Povidona/químicaRESUMEN
Potential usage of biodegradable and biocompatible polymeric nanofibers is the most attention grabbing topic for the drug delivery system. In order to fabricate ultrafine fibers, electrospinning, one of the well-known techniques, has been extensively studied in the literature. In the present study, the objective is to achieve the optimum blend of hydrophobic and hydrophilic polymers to be used as a drug delivery vehicle and also to obtain the optimum amount of doxycycline (DOXH) to reach the optimum release. In this case, the biodegradable and biocompatible synthetic polymers, poly(ε-caprolactone) (PCL) and poly(ethylene oxide) (PEO), were blended with different ratios for the production of DOXH-loaded electrospun PCL/PEO membranes using electrospinning technique, which is a novel attempt. The fabricated membranes were subsequently characterized to optimize the blending ratio of polymers by scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR), X-ray diffraction analysis (XRD) and water contact angle analysis. After the characterization studies, different amounts of DOXH were loaded to the optimized blend of PCL and PEO to investigate the release of DOXH from the membrane used as a drug delivery vehicle. In vitro drug release studies were performed, and in vitro drug release kinetics were assessed to confirm the usage of these nanofiber materials as efficient drug delivery vehicles. The results indicated that 3.5% DOXH-loaded (75:25 w/w) PCL/PEO is the most acceptable membrane to provide prolonged release rather than immediate release of DOXH.